Impact of Morphine on Early Recovery After Anterior Cruciate Ligament Reconstruction: A Case-Control Study
- 1Orthopedic Surgery, Clinique du Sport, Paris, FRA
- 2Orthopaedic Surgery, Clinique du Sport, Paris, FRA
Abstract
Purpose
Effective pain management is crucial in postoperative recovery after Anterior Cruciate Ligament Reconstruction (ACLR). To examine the effectiveness of the new opioid-containing protocol compared to another previously published protocol based on Nefopam and dynamic compression cryotherapy.Methods
This retrospective analysis of prospectively collected data was conducted at a sports surgery center between 2023 and 2024, including 1116 patients undergoing primary isolated ACLR. Patients were divided into two matched groups based on postoperative pain management: the opioid group (N=556), treated with oral morphine sulfate (Actiskenan®) as needed in addition to multimodal analgesia (e.g., paracetamol, nefopam, and ketoprofen), and the non-opioid group N=556, treated with multimodal analgesia alone. Patients were matched for age, sex, BMI, Lysholm score, Tegner score, meniscal injury, and chondropathy. The primary outcome was pain on the visual analogue scale (VAS) in the early postoperative period, analyzed in relation to the minimal clinically important difference (MCID) and the patient acceptable symptom state (PASS) thresholds for VAS. The secondary outcome was side effects, including nausea, dizziness, vomiting, anxiety, and abdominal pain, as well as early complications and revision rate.Results
The mean age in both groups was comparable (32.2 ± 9.4 years in the non-opioid group [N = 556] and 32.5 ± 10.0 years in the opioid group [N = 556], p = 0.867). Both groups predominantly used the quadrupled hamstring graft technique (440/556, 80.0% vs. 438/556, 79.9%, p = 0.4455). Preoperative scores were similar (p > 0.05). Postoperative pain was higher in the non-opioid group: day 0 VAS scores were 5.6 ± 2.7 (n = 536/556) vs. 5.3 ± 2.7 (n = 522/556) (p = 0.0339), and night pain was more common (379/556, 68.2% vs. 341/556, 61.3%, p = 0.0202). This trend continued on day 1 (5.2 ± 2.4 [n = 545/556] vs. 4.8 ± 2.4 [n = 543/556], p = 0.0014), day 2 (4.5 ± 2.4 [n = 551/556] vs. 4.2 ± 2.3 [n = 550/556], p = 0.0182), and day 3 (3.8 ± 2.3 [n = 551/556] vs. 3.4 ± 2.2 [n = 551/556], p = 0.0080). The non-opioid group had higher rates of dizziness on day 0 (100/536, 18.7% vs. 70/522, 13.4%, p = 0.0236). There was a trend toward higher complications in the non-opioid group (11/556, 2.0% vs. 3/556, 0.5%, p = 0.0558), mainly due to Cyclops syndrome and knee stiffness. Reoperation rates were similar (p > 0.05).Conclusion
Adding morphine to the postoperative protocol was associated with reduced postoperative pain in the first 3 days postoperatively and dizziness on the first day. However, while statistically significant, the mean difference in VAS scores did not exceed the MCID.
Related
- Beyond Physical Recovery: Psychological Factors and Assessment Tools in Return to Sport Decision-making after Anterior Cruciate Ligament Reconstruction – A Scoping Review
- Testosterone and Anterior Cruciate Ligament Injury and Reconstruction Outcomes: A Systematic Review and Meta-analysis
- Autograft Selection in Anterior Cruciate Ligament Reconstruction: A Meta-Analysis of Patellar Tendon versus Hamstring Tendon Outcomes in Randomized Controlled Trials
- Predicting 1-year outcomes after anterior cruciate ligament reconstruction from preoperative physical performance using machine learning: an exploratory study
- Barriers and Facilitators Influencing Physiotherapists’ Adherence to Clinical Practice Guidelines and Return to Sport Criteria after Anterior Cruciate Ligament Reconstruction: A Qualitative Study in Austria.
BibTeX
@article{moussa2026impact,
title = {{Impact of Morphine on Early Recovery After Anterior Cruciate Ligament Reconstruction: A Case-Control Study}},
author = {Mohamad K Moussa and Fethi Mrabet and Eugénie Valentin and Olivier Grimaud and Frederic Khiami and Antoine Gerometta and Alain Meyer and Nicolas Lefevre and Alexandre Hardy},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.117127},
url = {https://europepmc.org/article/PMC/PMC13717672},
note = {CC BY},
}
RIS
TY - JOUR
TI - Impact of Morphine on Early Recovery After Anterior Cruciate Ligament Reconstruction: A Case-Control Study
AU - Mohamad K Moussa
AU - Fethi Mrabet
AU - Eugénie Valentin
AU - Olivier Grimaud
AU - Frederic Khiami
AU - Antoine Gerometta
AU - Alain Meyer
AU - Nicolas Lefevre
AU - Alexandre Hardy
PY - 2026
DA - 2026/09/29
JO - Cureus
DO - 10.7759/cureus.117127
UR - https://europepmc.org/article/PMC/PMC13717672
AB - Purpose Effective pain management is crucial in postoperative recovery after Anterior Cruciate Ligament Reconstruction (ACLR). To examine the effectiveness of the new opioid-containing protocol compared to another previously published protocol based on Nefopam and dynamic compression cryotherapy.Methods This retrospective analysis of prospectively collected data was conducted at a sports surgery center between 2023 and 2024, including 1116 patients undergoing primary isolated ACLR. Patients were divided into two matched groups based on postoperative pain management: the opioid group (N=556), treated with oral morphine sulfate (Actiskenan®) as needed in addition to multimodal analgesia (e.g., paracetamol, nefopam, and ketoprofen), and the non-opioid group N=556, treated with multimodal analgesia alone. Patients were matched for age, sex, BMI, Lysholm score, Tegner score, meniscal injury, and chondropathy. The primary outcome was pain on the visual analogue scale (VAS) in the early postoperative period, analyzed in relation to the minimal clinically important difference (MCID) and the patient acceptable symptom state (PASS) thresholds for VAS. The secondary outcome was side effects, including nausea, dizziness, vomiting, anxiety, and abdominal pain, as well as early complications and revision rate.Results The mean age in both groups was comparable (32.2 ± 9.4 years in the non-opioid group [N = 556] and 32.5 ± 10.0 years in the opioid group [N = 556], p = 0.867). Both groups predominantly used the quadrupled hamstring graft technique (440/556, 80.0% vs. 438/556, 79.9%, p = 0.4455). Preoperative scores were similar (p > 0.05). Postoperative pain was higher in the non-opioid group: day 0 VAS scores were 5.6 ± 2.7 (n = 536/556) vs. 5.3 ± 2.7 (n = 522/556) (p = 0.0339), and night pain was more common (379/556, 68.2% vs. 341/556, 61.3%, p = 0.0202). This trend continued on day 1 (5.2 ± 2.4 [n = 545/556] vs. 4.8 ± 2.4 [n = 543/556], p = 0.0014), day 2 (4.5 ± 2.4 [n = 551/556] vs. 4.2 ± 2.3 [n = 550/556], p = 0.0182), and day 3 (3.8 ± 2.3 [n = 551/556] vs. 3.4 ± 2.2 [n = 551/556], p = 0.0080). The non-opioid group had higher rates of dizziness on day 0 (100/536, 18.7% vs. 70/522, 13.4%, p = 0.0236). There was a trend toward higher complications in the non-opioid group (11/556, 2.0% vs. 3/556, 0.5%, p = 0.0558), mainly due to Cyclops syndrome and knee stiffness. Reoperation rates were similar (p > 0.05).Conclusion Adding morphine to the postoperative protocol was associated with reduced postoperative pain in the first 3 days postoperatively and dizziness on the first day. However, while statistically significant, the mean difference in VAS scores did not exceed the MCID.
SN - 2168-8184
ER -